Action News Jax’s Phil Amato shares his experience with sudden sensorineural hearing loss

"I was driving home listening to the radio when something suddenly changed. By the time I pulled into my driveway, I realized ...
Forbes

New Gene Therapy For Rare Hearing Loss Wins FDA Approval—What To Know

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
MedPage Today

First Gene Therapy Approved for Hearing Loss

The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene ...
WebMD

Otarmeni: FDA Approves One-Time Gene Therapy for OTOF-Associated Genetic Hearing Loss

What Is Otarmeni, and Why Does It Matter? Otarmeni (lunsotogene parvec-cwha) is a single-use gene therapy for children and adults who have severe or profound hearing loss (a hearing level of more than ...
NPR

Gene therapy for a rare type of deafness shows lasting results

An experimental gene therapy appears safe and highly effective for restoring hearing to people born with a rare form of deafness, researchers reported Wednesday. The study, the largest and longest to ...
STAT

Gene therapy trial for deafness adds evidence to drug’s efficacy

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
The New York Times

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent. By Gina Kolata The Food and Drug ...
CNN

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a ...
Reuters

Regeneron wins FDA approval for first gene therapy for genetic hearing loss

April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's (REGN.O), opens new tab gene therapy ‌for a rare genetic form of deafness, the company said on Thursday. This ...
CNBC

Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss

Regeneron will make its newly approved gene therapy Otarmeni for a rare, genetic form of hearing loss available for free in the U.S. The company hasn't decided how it will price the therapy overseas, ...
New York Post

FDA OKs ‘life-changing’ gene therapy for hearing loss — and it’s free

You might like the sound of this news. In a landmark move, the Food and Drug Administration on Thursday approved the first gene therapy for a rare, inherited form of hearing loss. And while these ...